MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
ALZN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Alzamend Neuro (ALZN) Ownership - Who owns Alzamend Neuro?

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's disease... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
3480 Peachtree Road NE
Phone
+1 844 722-6333
Employees
7
Web
https://www.alzamend.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.28M
P/E Ratio
N/A
Total Cash
2.71M
Projected Growth
N/A
Total Debt
300.71K
Revenue
N/A
Risk (Beta)
0.41
Dividend Yield
N/A
Total Cash/Share
0.57
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
ALZN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for ALZN
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
3480 Peachtree Road NE
Phone
+1 844 722-6333
Employees
7
Web
https://www.alzamend.com